GlassScriptPhysician profile
Michael C Kearney
NPI 1386646909
$7,778.64
in general payments reported to CMS, 2019-2025
31 companies · $1,143 in 2025
The $1,143 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,483 · 2020: $632 · 2021: $220 · 2022: $98.13 · 2023: $2,986 · 2024: $1,217 · 2025: $1,143.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,997 · Travel and Lodging: $1,730 · Consulting Fee: $1,620.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,996.51 |
| Travel and Lodging | $1,729.54 |
| Consulting Fee | $1,620.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $2,755.90 | 2019-2025 | Lumenis Pulse 120h, Moses 550 Dfl, General - Erectile Dysfunction |
| Olympus Medical Systems Corporation | $1,620.00 | 2023 | Oes Choledochofiberscope |
| Calyxo, INC. | $550.83 | 2023-2025 | Cvac Aspiration System |
| Astellas Pharma US INC | $520.01 | 2019-2021 | |
| Teleflex LLC | $406.24 | 2021-2025 | Barrigel |
| Janssen Biotech, INC. | $215.79 | 2019-2020 | |
| Ferring Pharmaceuticals INC. | $207.38 | 2019-2025 | Adstiladrin |
| Abbvie INC. | $195.79 | 2019-2020 | |
| Procept Biorobotics Corporation | $137.68 | 2024 | Aquabeam System |
| Therapeuticsmd, INC. | $116.53 | 2019 | |
| Allergan, INC. | $115.94 | 2019-2020 | |
| Antares Pharma, INC. | $95.58 | 2019-2020 | |
| Pfizer INC. | $95.01 | 2019-2020 | |
| C. R. Bard, INC. & Subsidiaries | $69.56 | 2019 | |
| Tolmar Pharmaceuticals, INC. | $69.03 | 2019-2020 |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Dendreon Pharmaceuticals LLC | $58.80 | 2019 | |
| Travere Therapeutics, INC. | $56.37 | 2020 | |
| Endo Pharmaceuticals INC. | $54.95 | 2019-2020 | |
| Healthtronics Stone Solutions, LLC | $54.69 | 2019 | |
| Urogen Pharma, INC. | $53.16 | 2021-2025 | |
| Blue Earth Diagnostics | $44.18 | 2019 | |
| Aytu Biopharma, INC. | $43.39 | 2019-2020 | |
| Laborie Medical Technologies Corp. | $35.88 | 2020-2024 | Optilume Bph Drug Coated Balloon Catheter |
| Rochester Medical Corporation | $35.38 | 2019-2020 | |
| Neotract INC. | $34.01 | 2019 | |
| Coloplast Corp | $32.74 | 2020 | |
| Agiliti Surgical, INC. | $31.57 | 2024 | Sonablate Hifu |
| Amgen INC. | $25.02 | 2020 | |
| 180 Medical, INC. | $19.91 | 2019 | |
| Acerus Pharmaceuticals Corporation | $16.02 | 2020 | |
| Medtronic USA, INC. | $11.30 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Kearney listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.